Rigel Pharmaceuticals
RIGL
Rigel Pharmaceuticals (RIGL) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Neutral | $49.00 from $40.00 | Aug 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $85.00 from $57.00 | Aug 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Jun 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | May 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | May 22, 2026 |
| Citigroup | Maintained | Buy | $81.00 from $69.00 | May 13, 2026 |
| Citigroup | Maintained | Buy | $69.00 from $71.00 | May 7, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $38.00 from $32.00 | Nov 5, 2025 |
| Jefferies | Upgraded | Hold → Buy | $42.00 from $23.00 | Nov 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Oct 8, 2025 |
| Cantor Fitzgerald | Maintained | Neutral | $32.00 from $23.00 | Aug 6, 2025 |
| Cantor Fitzgerald | Maintained | Neutral | $23.00 from $20.00 | May 7, 2025 |
| Citigroup | Maintained | Buy | $55.00 from $49.00 | Mar 6, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Mar 5, 2025 |
| B. Riley Securities | Maintained | Neutral | $24.00 from $20.00 | Mar 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Jan 23, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Jan 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Jan 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $57.00 | Dec 10, 2024 |
| B. Riley Securities | Maintained | Neutral | $20.00 from $27.00 | Dec 10, 2024 |
Frequently asked questions
What is the latest analyst rating on RIGL?
On Aug 17, 2026, Piper Sandler maintained Rigel Pharmaceuticals at Neutral with a price target of $49.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.